Tag Archives: side effects
GSH reduces toxicity of cisplatin in women with ovarian cancer
PAPR Inhibitors May Work Against More Ovarian Cancers
PAPR inhibitors, first used in trials for women with ovarian cancer who had a mutation in the BRCA1 or BRCA2 gene, are now being used in trials for women without … Continue reading
Posted in News
Also tagged clinical trials, genetics, recurrence, Research, science, treatment
Leave a comment
Drug Combination to Treat Cancer Expected to Rise
According to an article in the Wall Street Journal, combinations of drugs to treat cancer will be used more frequently in the future. Many studies presented at the 2011 annual … Continue reading
Carbo/Doxil in elderly patients
BACKGROUND: CALYPSO (CAeLYx in Platinum Sensitive Ovarian) patients compared carboplatin-pegylated liposomal doxorubicin (C-PLD) with carboplatin-paclitaxel (C-P) in patients with late-relapsing recurrent ovarian cancer (ROC). We analyzed outcomes in patients <70 … Continue reading
ESAs Linked to Ovarian Cancer Mortality (Medpage)
A study presented at the Society for Gynecologic Oncology annual meeting in March, 2011 showed that women treated with ESAs had higher rates of ovarian cancer recurrence and death. ESAs … Continue reading
ASCO Recommends Steps to Improve Doctor-Patient Communication about End-of-Life Cancer Care
The American Society of Clinical Oncology released a policy statement recommending “steps to ensure that physicians initiate candid discussions about the full range of palliative care and treatment options soon … Continue reading
Many Cancer Patients Have Chronic Pain
A new study released shows that more than 40 percent of cancer patients have pain women and black have a higher risk of experiencing pain both cancer surgery and cancer treatment … Continue reading
Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: A Randomized Multicenter Phase II Trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group
Purpose Weekly administration of topotecan (Tw) is less toxic and widely considered a better treatment option than conventional 5-day therapy (Tc) in women with platinum-resistant recurrent ovarian cancer. We conducted … Continue reading
FDA approves opioid analgesic to help cancer patients manage pain
FDA approves opioid analgesic to help cancer patients manage pain Enrollment in REMS program required for health care professionals The U.S. Food and Drug Administration today approved Abstral (fentanyl) transmucosal … Continue reading
Harms often surface years after cancer drug approval
Serious and sometimes life-threatening side effects often go unreported until years after cancer drugs have been approved, Canadian researchers said Monday. Within four years of approval, five of the 12 … Continue reading
FDA approves Xgeva to help prevent cancer-related bone injury
The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related … Continue reading
Cancer Patients’ Secondary Symptoms Need Attention: Study
Many with pain, depression also bothered by fatigue, nausea and dry mouth, experts say Many cancer patients with pain or depression also experience physical symptoms, such as fatigue, dry mouth … Continue reading
